Borja E. Sanz-Cuesta, Jeffrey L. Saver: Lipid-Lowering Therapy and Hemorrhagic Stroke Risk: Comparative Meta-Analysis of Statins and PCSK9 Inhibitors. Stroke, 2021-10, 52. vsk, nro 10, s. 3142–3150. doi:10.1161/STROKEAHA.121.034576ISSN 0039-2499Artikkelin verkkoversio. (englanniksi)
University Hospital, Bordeaux: Mortality and Economic Impact of Stopping Statins in People Aged of 75 and Over: a Pragmatic Clinical Trial. National Library of Medicine, 3.12.2020, nro NCT02547883. clinicaltrials.gov. Artikkelin verkkoversio.
Borja E. Sanz-Cuesta, Jeffrey L. Saver: Lipid-Lowering Therapy and Hemorrhagic Stroke Risk: Comparative Meta-Analysis of Statins and PCSK9 Inhibitors. Stroke, 2021-10, 52. vsk, nro 10, s. 3142–3150. doi:10.1161/STROKEAHA.121.034576ISSN 0039-2499Artikkelin verkkoversio. (englanniksi)
Chuannan Zhai, Kai Hou, Rui Li, YueCheng Hu, JingXia Zhang, YingYi Zhang: Efficacy of statin treatment based on cardiovascular outcomes in elderly patients: a standard meta-analysis and Bayesian network analysis. The Journal of International Medical Research, 12.6.2020, nro 6. PubMed:32529863doi:10.1177/0300060520926349ISSN 0300-0605Artikkelin verkkoversio.
Christie M. Ballantyne, Joel S. Raichlen, Valerie A. Cain: Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients: the MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin) trial. Journal of the American College of Cardiology, 19.8.2008, nro 8, s. 626–632. PubMed:18702965doi:10.1016/j.jacc.2008.04.052ISSN 1558-3597Artikkelin verkkoversio.
Beatrice A. Golomb, Joel E. Dimsdale, Hayley J. Koslik, Marcella A. Evans, Xun Lu, Steven Rossi: Statin Effects on Aggression: Results from the UCSD Statin Study, a Randomized Control Trial. PLOS ONE, 7.1.2015, nro 10, s. e0124451. PubMed:26132393doi:10.1371/journal.pone.0124451ISSN 1932-6203Artikkelin verkkoversio. (englanniksi)
J. A. Pio-Magalhães, M. C. Ferreira-Sae, F. A. Souza, A. M. Grespan-Magossi, R. Schreiber, L. A. Velloso: Hip circumference is associated with high density lipoprotein cholesterol response following statin therapy in hypertensive subjects. Journal of Endocrinological Investigation, 2011-10, nro 34, s. 680–684. PubMed:21586895doi:10.3275/7725ISSN 1720-8386Artikkelin verkkoversio.
Lipid-Lowering Agents in Older Individuals: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. The Journal of Clinical Endocrinology & Metabolism, Volume 104, Issue 5, May 2019, Pages 1585–1594. https://doi.org/10.1210/jc.2019-00195
Strandberg, Timo: Onko statiineista sienilääkkeeksi. Lääkärilehti, 26.1.2026. Helsinki: Suomen Lääkäriliitto ry. ISBN 2489-7434 Artikkelin verkkoversio. (Verkkoversio) Viitattu 27.1.2026.
Chuannan Zhai, Kai Hou, Rui Li, YueCheng Hu, JingXia Zhang, YingYi Zhang: Efficacy of statin treatment based on cardiovascular outcomes in elderly patients: a standard meta-analysis and Bayesian network analysis. The Journal of International Medical Research, 12.6.2020, nro 6. PubMed:32529863doi:10.1177/0300060520926349ISSN 0300-0605Artikkelin verkkoversio.
Christie M. Ballantyne, Joel S. Raichlen, Valerie A. Cain: Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients: the MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin) trial. Journal of the American College of Cardiology, 19.8.2008, nro 8, s. 626–632. PubMed:18702965doi:10.1016/j.jacc.2008.04.052ISSN 1558-3597Artikkelin verkkoversio.
Beatrice A. Golomb, Joel E. Dimsdale, Hayley J. Koslik, Marcella A. Evans, Xun Lu, Steven Rossi: Statin Effects on Aggression: Results from the UCSD Statin Study, a Randomized Control Trial. PLOS ONE, 7.1.2015, nro 10, s. e0124451. PubMed:26132393doi:10.1371/journal.pone.0124451ISSN 1932-6203Artikkelin verkkoversio. (englanniksi)
J. A. Pio-Magalhães, M. C. Ferreira-Sae, F. A. Souza, A. M. Grespan-Magossi, R. Schreiber, L. A. Velloso: Hip circumference is associated with high density lipoprotein cholesterol response following statin therapy in hypertensive subjects. Journal of Endocrinological Investigation, 2011-10, nro 34, s. 680–684. PubMed:21586895doi:10.3275/7725ISSN 1720-8386Artikkelin verkkoversio.
Chuannan Zhai, Kai Hou, Rui Li, YueCheng Hu, JingXia Zhang, YingYi Zhang: Efficacy of statin treatment based on cardiovascular outcomes in elderly patients: a standard meta-analysis and Bayesian network analysis. The Journal of International Medical Research, 12.6.2020, nro 6. PubMed:32529863doi:10.1177/0300060520926349ISSN 0300-0605Artikkelin verkkoversio.
Beatrice A. Golomb, Joel E. Dimsdale, Hayley J. Koslik, Marcella A. Evans, Xun Lu, Steven Rossi: Statin Effects on Aggression: Results from the UCSD Statin Study, a Randomized Control Trial. PLOS ONE, 7.1.2015, nro 10, s. e0124451. PubMed:26132393doi:10.1371/journal.pone.0124451ISSN 1932-6203Artikkelin verkkoversio. (englanniksi)
Prasanna Padmanabham, Stephen Liu, Daniel Silverman: Lipophilic Statins in Subjects with Early Mild Cognitive Impairment: Associations with Conversion to Dementia and Decline in Posterior Cingulate Brain Metabolism in a Long-term Prospective Longitudinal Multi-Center Study. Journal of Nuclear Medicine, 1.5.2021, nro supplement 1, s. 102–102. ISSN 0161-5505Artikkelin verkkoversio. (englanniksi)
Borja E. Sanz-Cuesta, Jeffrey L. Saver: Lipid-Lowering Therapy and Hemorrhagic Stroke Risk: Comparative Meta-Analysis of Statins and PCSK9 Inhibitors. Stroke, 2021-10, 52. vsk, nro 10, s. 3142–3150. doi:10.1161/STROKEAHA.121.034576ISSN 0039-2499Artikkelin verkkoversio. (englanniksi)
Chuannan Zhai, Kai Hou, Rui Li, YueCheng Hu, JingXia Zhang, YingYi Zhang: Efficacy of statin treatment based on cardiovascular outcomes in elderly patients: a standard meta-analysis and Bayesian network analysis. The Journal of International Medical Research, 12.6.2020, nro 6. PubMed:32529863doi:10.1177/0300060520926349ISSN 0300-0605Artikkelin verkkoversio.
Christie M. Ballantyne, Joel S. Raichlen, Valerie A. Cain: Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients: the MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin) trial. Journal of the American College of Cardiology, 19.8.2008, nro 8, s. 626–632. PubMed:18702965doi:10.1016/j.jacc.2008.04.052ISSN 1558-3597Artikkelin verkkoversio.
Prasanna Padmanabham, Stephen Liu, Daniel Silverman: Lipophilic Statins in Subjects with Early Mild Cognitive Impairment: Associations with Conversion to Dementia and Decline in Posterior Cingulate Brain Metabolism in a Long-term Prospective Longitudinal Multi-Center Study. Journal of Nuclear Medicine, 1.5.2021, nro supplement 1, s. 102–102. ISSN 0161-5505Artikkelin verkkoversio. (englanniksi)
Beatrice A. Golomb, Joel E. Dimsdale, Hayley J. Koslik, Marcella A. Evans, Xun Lu, Steven Rossi: Statin Effects on Aggression: Results from the UCSD Statin Study, a Randomized Control Trial. PLOS ONE, 7.1.2015, nro 10, s. e0124451. PubMed:26132393doi:10.1371/journal.pone.0124451ISSN 1932-6203Artikkelin verkkoversio. (englanniksi)
J. A. Pio-Magalhães, M. C. Ferreira-Sae, F. A. Souza, A. M. Grespan-Magossi, R. Schreiber, L. A. Velloso: Hip circumference is associated with high density lipoprotein cholesterol response following statin therapy in hypertensive subjects. Journal of Endocrinological Investigation, 2011-10, nro 34, s. 680–684. PubMed:21586895doi:10.3275/7725ISSN 1720-8386Artikkelin verkkoversio.